Notably, the silencing of NCAPG2 effectively reversed the tumor‐promoting effects induced by RPL35A in HCC cells, underscoring the regulatory association between RPL35A and NCAPG2. This evidence concerns the gene NCAPG2 and hepatocellular carcinoma.